Comparing two new heart valves for TAVI
Part of Heart & circulation clinical trials.
This trial compares two newer types of heart valves (Evolut FX and Sapien 3 Ultra Resilia) used in a procedure called TAVI, which replaces a narrowed heart valve without open-heart surgery. It is for people who are good candidates for both valves and can have the procedure through a leg artery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- A team of heart doctors (heart team) has agreed that both types of valves (Evolut FX and Sapien 3 Ultra Resilia) are good options for you.
- You will have the valve replacement through a blood vessel in your leg (femoral artery).
- You are willing to sign a consent form to join the study.
- The hospital where you have the procedure does a lot of these valve replacements (more than 75 a year).
- The doctor doing the procedure has experience with both types of valves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to position the Evolut FX+ valve in people with severe aortic stenosis. The goal is to improve how the valve lines up with your own heart structure, which may help it work better.
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
This study is testing a new heart valve called the SAPIEN 3 Ultra RESILIA valve for people with severe aortic stenosis. Researchers want to see how well it works and how safe it is over 10 years after a minimally invasive valve replacement procedure called TAVI.
This trial compares two methods (ultrasound vs X-ray) to guide a minimally invasive heart valve replacement procedure for people with severe aortic stenosis. The goal is to see if using ultrasound alone is as safe and effective as using X-ray.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
This trial tests a new heart valve called DurAVR for people with severe aortic stenosis (a narrowed aortic valve) who need a valve replacement. It compares the new valve to standard valves to see if it is safe and works well.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.